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A B S T R A C T  
Background: The irrational use of antibiotics in outpatient as well as indoor patients without studying the culture and 
sensitivity patterns may have led to resistance in common organisms causing acute exacerbation of chronic 
obstructive pulmonary disease. The objective of this study was to determine the culture and sensitivity patterns of 
bacteria in the sputum of patients presenting with acute exacerbation of chronic obstructive pulmonary disease 
(COPD) in our population. 
Material and Methods: This cross-sectional study was conducted in the Medicine Department, Jinnah Hospital Lahore 
from 1st January 2018 to 25th June 2018. A total of 215 patients with acute exacerbation of COPD were collected 
through non-probability consecutive sampling technique. COPD was diagnosed on the basis of history, examination, 
chest X-ray and spirometry. Acute exacerbation was taken as an acute rise in one or more of the following; sputum 
volume and/or purulence, frequency and severity of cough and dyspnea. Two sputum samples were collected from 
each patient. Antimicrobial susceptibility testing was done as per CLSI guidelines. Data was analyzed by SPSS  version 
21.0. with p-value ≤ 0.05 considered as statistically significant. 
Results: Among 215 selected cases, 118 (54.88%) were males and 97 (45.12%) were females. A total of 110 (51.16%) 
cultures were positive and 105 (48.84%) were negative for bacterial growth. Klebsiella pneumoniae (n=69; 62.72%) 
was the most frequent microorganism in patient’s sputum followed by Pseudomonas aeruginosa (n=21; 19.1%) and 
Staphylococcus aureus (n=20; 18.2%). Regarding sensitivity pattern, amikacin was found to be the most sensitive 
antibiotic against these organisms followed by gentamicin and ciprofloxacin. 
Conclusion(s): Klebsiella pneumoniae was the most common microorganism in the sputum of patients presenting with 
acute exacerbation of COPD, while amikacin was reported to be most sensitive antibiotic against the microorganism. 
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I n t r o d u ct i on  
 
Chronic obstructive pulmonary disease (COPD) is a 
lung disease categorized by the chronic obstruction 
to lung airflow that affects normal breathing.1 It is 
emerging as the fourth communal reason of 
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morbidity and mortality around the world 
triggering more than 3 million deaths every year.2 
Globally, it is predicted  that in 2020 it will be the 
third common cause of death.3 Currently the 
burden of this disease in Asia is greater than that in 
the developed Western world, both in terms of 
mortality and the morbidity.4 
Acute exacerbation of COPD (AECOPD) is a 
recurrent event throughout the chronic course of 
this sickness.5 AECOPD is well-defined as an acute 
rise in one or more of the following; sputum 
volume and/or purulence, frequency and severity 
of cough and dyspnea.6 Bacterial infections are 
considered to be causing 30-50% of acute 
exacerbations.7 
The occurrence of COPD is highest in elderly aged 
more than 65 years of age. Antibiotics are 
considered to improve the outcomes in 
management of Acute Exacerbation of COPD 
(AEOCOPD).8 But still there are many difficulties in 
the management of such patients. The problem is 
the emergence of resistance to antibiotics, used 
against common bacterial pathogens responsible 
for acute exacerbations. The most common cause 
of this problem is unnecessary use and excessive 
exposure of these bacterial organisms to 
antibiotics.9 A local study done in Karachi revealed 
the emergence of resistance in isolates of Klebsiella 
pneumoniae and Pseudomonas aeruginosa against 
different quinolones.10 Various studies carried out 
in different parts of the world have shown variation 
in the culture and sensitivity patterns in this group 
of patients.  
In our population, the irrational use of antibiotics in 
outpatient and indoor patients without studying 
the culture and sensitivity patterns may have led to 
resistance in common organisms causing 
AEOCOPD. There is scarcity of data regarding the 
issue especially in our set up. So, this study was 
designed to determine the most common 
microorganisms causing AEOCOPD in our 
population followed by finding the sensitivity 
patterns of these bacteria against various 
antibiotics. 
M a t e r i a l  a n d  M e t h od s  
This cross-sectional study was conducted at 
Medicine Department of Jinnah Hospital Lahore 
from 1st January 2018 to 25th June 2018. The sample 
size was calculated as 215 using 95% confidence 
level, 3.5% margin of error, and 7.3% as expected 
percentage of Pseudomonas aeruginosa in patients 
with AEOCOPD.11 
Non-probability consecutive sampling technique 
was used. Sputum samples were collected from 215 
patients with acute exacerbation of COPD, after 
rinsing the mouth twice with plain water. Samples 
were collected in sterile jars, properly labeled with 
the name and registration number of the patient 
before sending to the Pathology Department of 
Allama Iqbal Medical College, Lahore. 
Each sample was processed for bacterial culture 
and sensitivity as per standard microbiological 
techniques. Antimicrobial susceptibility testing was 
done as per CLSI guidelines. Newly or previously 
diagnosed patients of COPD both male and female, 
aged 25-80 years presenting in OPD or emergency 
departments with acute exacerbations were 
included in study. COPD was diagnosed on the basis 
of history, examination, and Chest X-ray (PA) view. 
Post bronchodilator FEV1/FVC ratio of <0.70 by 
spirometry was taken as confirmatory for COPD. 
Acute exacerbation was taken as an acute rise in 
one or more of the following; sputum volume 
and/or purulence, frequency and severity of cough 
and dyspnea. Exclusion Criteria included (i) all cases 
with evidence of pneumonia or bronchiectasis 
(based on history, examination, and CXR) 
developed as a sequela of other disease, pulmonary 
tuberculosis (determined by 3 early morning 
sputum samples for AFB), cystic fibrosis 
(determined by CT chest) (ii) patients who were 
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already on antibiotics (determined by taking drug 
history). (iii) patients with other chronic ailments 
like congestive cardiac failure, chronic kidney 
disease, chronic liver disease (based on history, 
examination, CXR, echocardiogram, ultrasound 
abdomen, renal function tests and liver function 
tests). Patients were divided into two age groups; 
25-50 years and 51-80 years. Data was analyzed by 
SPSS v 21.0. Mean and standard deviation was 
calculated for quantitative variables such as age. 
For qualitative variables like gender and micro-
organisms, frequency and percentages were 
analyzed. Chi-square test was applied to find out 
the association of micro-organisms with age, 
gender and duration of disease.  P-value ≤ 0.05 was 
considered as statistically significant. 
R e s u l t s  
Among 215 selected cases, 118 (54.88%) were male  
and 97 (45.12%) were female with a mean age of 
53.98+10.29 years. There were 83 (38.6%) patients 
in 25-50 years age group and 132 (61.4%) in 51-80 
years age group. Regarding duration of disease, 139 
(64.65%) patients had 1-6 months of disease history 
and 76 (35.35%) had history of more than 6 months 
of duration. A total of 110 (51.16%) cultures were 
positive and 105 (48.84%) were negative for 
bacterial growth. Klebsiella pneumoniae (n=69; 
62.72%) was the most frequent microorganism 
found in patient’s sputum followed by 
Pseudomonas aeruginosa (n=21; 19.1%) and 
Staphylococcus aureus (n=20; 18.2%).  
Regarding sensitivity pattern, amikacin was found 
to be most sensitive antibiotic. Amikacin and 
gentamicin showed highest sensitivity for 
Pseudomonas aeruginosa followed by 
Staphylococcus aureus and Klebsiella pneumoniae 
(Figure 1). Ciprofloxacin exhibited maximum 
sensitivity for Staphylococcus aureus followed by 
Pseudomonas aeruginosa and Klebsiella 
pneumoniae (Figure 1). 
 
Figure 1: Frequency of antibiotics sensitivity pattern 
against common microorganisms (n=110). 
 
Pseudomonas aeruginosa and Staphylococcus 
aureus have no significant association with age, 
gender and duration of disease. Klebsiella 
pneumonia was found to be more prevalent among 
males as compared to females. Association of 
Klebsiella pneumoniae with age and duration of 
disease was statistically insignificant (Table I). 
D i s c u s s i o n  
Infections are the main reasons for AECOPD which 
result in significant mortality and morbidity.12 The 
present study determines the bacterial culture  and 
sensitivity patterns in the sputum of patients 
presenting with AECOPD. In the light of this study 
we can find the most appropriate empirical 
antibiotic therapy for the management of such 
patients in future, as the choice of antibiotics 
should be modified according to local bacterial 
culture and sensitivity patterns. Likewise, studies 
have shown different sensitivity patterns to most 
commonly used drugs including penicillin, 
macrolides and fluoroquinolones.13 
The wide use of these antibiotics in our hospitals 
may lead to resistance and decreased response of 
lower respiratory tract infections which can result 
in problems managing these patients.14 
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+ ve-positive for bacterial growth; - ve-negative for bacterial growth
Moreover, the COPD patients are likely to develop 
resistance to antibiotics over time, especially those 
with productive cough. It has been reported that 
23.5% patients with COPD will develop resistance 
to an antibiotic within the period of 28.4 months of 
follow-up, with sputum producers considered as 
having a higher risk.15 This emphasizes the 
significance of investigating sputum samples with 
determination of resistance patterns. 
Our findings are supported by a study conducted in 
Hyderabad India in which cultures were positive for 
Gram-negative bacteria in 50% of the patients 
(n=81). The commonest bacteria were Klebsiella 
pneumoniae (59%) followed by Pseudomonas 
aeruginosa (15%), Staphylococcus aureus (13.6%), 
Streptococcus pneumoniae (6.8%) and 
Streptococcus pyogenes (4.5%), respectively.16 
Similar findings reported by Pradhan et al18 who 
isolated Klebsiella pneumoniae in most of the 
culture-positive cases of chronic respiratory 
diseases. The gram-negative bacteria were sensitive 
to amikacin followed by gentamicin and 
ciprofloxacin. These drugs are available in most of 
the primary health care settings of our country and 
resistance could have developed by positive 
selection as COPD patients take antibiotics often 
for their symptoms. 
Sputum culture is a simple method to find the 
causative pathogen and bacterial sensitivity pattern 
for AECOPD patients. It aids in screening drug-
resistant microbes and the selection of superior 
antibacterial drugs for treatment. The results of our 
study are primary in our population; larger trials 
should be conducted to validate our findings for 
authentication. 
Limitation: This was a single center study with a 
small sample size, due to time constraints and 
funding limitations 
C o n c l u s i on  
Klebsiella pneumoniae followed by Pseudomonas 
aeruginosa and Staphylococcus aureus are the most 
common microorganisms in the sputum of patients 
presenting with an acute exacerbation of COPD, 
while amikacin was found to be the most sensitive 
antibiotic against these microorganisms. 
R e c o m m e n d a t i o n  
Sputum culture and sensitivity is highly 
recommended in patient presenting with COPD. 
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